Douglas A Rubinson

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 36

Top Topics

Squamous Cell Carcinoma

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer discovery

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Harshabad Singh, Kristen E Lowder, Kevin Kapner, Ronan J Kelly, Hui Zheng, Nadine Jackson McCleary, Thomas A Abrams, Jennifer A Chan, Eileen M Regan, Samuel J Klempner, Alison M Hannigan, Joshua Remland, Lauren K Brais, Elizabeth Andrews, Matthew B Yurgelun, James M Cleary, Douglas A Rubinson, Lauren L Ritterhouse, Garrett Maron, Andrew J Aguirre, Jeffrey A Meyerhardt, Emma Gardecki, Jochen K Lennerz, Brian M Wolpin, Peter C Enzinger
Clinical outcomes and ctDNA correlates for CAPOX BETR: a phase II trial of capecitabine, oxaliplatin, bevacizumab, trastuzumab in previously untreated advanced HER2+ gastroesophageal adenocarcinoma. Nature communications 15 (1) (2024)
Harshabad Singh, Pranshu Sahgal, Kevin S Kapner, Steven M Corsello, Hersh V Gupta, Rahul Gujrathi, Yvonne Y Li, Andrew D Cherniak, Raquelle El Alam, Joseph A Kerfoot, Elizabeth Andrews, Annette Lee, Chetan Nambiar, Alison M Hannigan, Joshua Remland, Lauren K Brais, Meghan E Leahy, Douglas A Rubinson, Benjamin L Schlechter, Matthew L Meyerson, Yanan Kuang, Cloud P Paweletz, Jessica K Lee, Julia Coelho França Quintanilha, Andrew J Aguirre, Kimberley J Perez, Brandon M Huffman, Humberto Rossi, Thomas A Abrams, Sheheryar K Kabraji, Livio Trusolino, Andrea Bertotti, Ewa T Sicinska, Aparna Raj Parikh, Brian M Wolpin, Alexa B Schrock, Marios Giannakis, Kimmie Ng, Jeffrey A Meyerhardt, Jason L Hornick, Nilay S Sethi, James M Cleary
RAS/RAF co-mutation and ERBB2 copy number modulates HER2 heterogeneity and responsiveness to HER2-directed therapy in colorectal cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Paul E Oberstein, Andressa Dias Costa, Emily A Kawaler, Victoire Cardot-Ruffino, Osama E Rahma, Nina Beri, Harshabad Singh, Thomas A Abrams, Leah H Biller, James M Cleary, Peter Enzinger, Brandon M Huffman, Nadine Jackson McCleary, Kimberley J Perez, Douglas A Rubinson, Benjamin L Schlechter, Rishi Surana, Matthew B Yurgelun, S Jennifer Wang, Joshua Remland, Lauren K Brais, Naima Bollenrucher, Eugena Chang, Lestat R Ali, Patrick J Lenehan, Igor Dolgalev, Gregor Werba, Cibelle Lima, C Elizabeth Keheler, Keri M Sullivan, Michael L Dougan, Cristina Hajdu, Maya Dajee, Marc R Pelletier, Saloney Nazeer, Matthew Squires, Dafna Bar-Sagi, Brian M Wolpin, Jonathan Andrew Nowak, Diane M Simeone, Stephanie K Dougan
Blockade of IL-1β and PD-1 with combination chemotherapy reduces systemic myeloid suppression in metastatic pancreatic cancer with heterogeneous effects in the tumor. Cancer immunology research (2024)
Paul E Oberstein, Andressa Dias Costa, Emily A Kawaler, Victoire Cardot-Ruffino, Osama E Rahma, Nina Beri, Harshabad Singh, Thomas A Abrams, Leah H Biller, James M Cleary, Peter Enzinger, Brandon M Huffman, Nadine Jackson McCleary, Kimberley J Perez, Douglas A Rubinson, Benjamin L Schlechter, Rishi Surana, Matthew B Yurgelun, S Jennifer Wang, Joshua Remland, Lauren K Brais, Naima Bollenrucher, Eugena Chang, Lestat R Ali, Patrick J Lenehan, Igor Dolgalev, Gregor Werba, Cibelle Lima, C Elizabeth Keheler, Keri M Sullivan, Michael L Dougan, Cristina Hajdu, Maya Dajee, Marc R Pelletier, Saloney Nazeer, Matthew Squires, Dafna Bar-Sagi, Brian M Wolpin, Jonathan Andrew Nowak, Diane M Simeone, Stephanie K Dougan
Blockade of IL-1β and PD-1 with combination chemotherapy reduces systemic myeloid suppression in metastatic pancreatic cancer with heterogeneous effects in the tumor. Cancer immunology research (2024)
Douglas A Rubinson, Noritaka Tanaka, Ferran Fece de la Cruz, Kevin S Kapner, Michael H Rosenthal, Bryanna L Norden, Haley Barnes, Sara Ehnstrom, Alvin A Morales-Giron, Lauren K Brais, Christopher T Lemke, Andrew J Aguirre, Ryan B Corcoran
Sotorasib is a pan-RASG12C inhibitor capable of driving clinical response in NRASG12C cancers. Cancer discovery (2024)
Brandon M Huffman, Harshabad Singh, Lestat R Ali, Nora Horick, S Jennifer Wang, Megan T Hoffman, Katherine A Metayer, Shayla Murray, Alexandra Bird, Thomas A Abrams, Leah H Biller, Jennifer A Chan, Jeffrey A Meyerhardt, Nadine J McCleary, Wolfram Goessling, Anuj K Patel, Jeffrey S Wisch, Matthew B Yurgelun, Kent Mouw, Brendan Reardon, Eliezer Van Allen, Jessica A Zerillo, Jeffrey W Clark, Aparna Parikh, Robert J Mayer, Benjamin Schlechter, Kimmie Ng, Sunil Kumar, Catherine Del Vecchio Fitz, Charlotte Kuperwasser, Glenn J Hanna, Andrew L Coveler, Douglas A Rubinson, Emma L Welsh, Kathleen Pfaff, Scott Rodig, Stephanie K Dougan, James M Cleary
Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders. Journal for immunotherapy of cancer 12 (1) (2024)
Brandon M Huffman, Harshabad Singh, Lestat R Ali, Nora Horick, S Jennifer Wang, Megan T Hoffman, Katherine A Metayer, Shayla Murray, Alexandra Bird, Thomas A Abrams, Leah H Biller, Jennifer A Chan, Jeffrey A Meyerhardt, Nadine J McCleary, Wolfram Goessling, Anuj K Patel, Jeffrey S Wisch, Matthew B Yurgelun, Kent Mouw, Brendan Reardon, Eliezer Van Allen, Jessica A Zerillo, Jeffrey W Clark, Aparna Parikh, Robert J Mayer, Benjamin Schlechter, Kimmie Ng, Sunil Kumar, Catherine Del Vecchio Fitz, Charlotte Kuperwasser, Glenn J Hanna, Andrew L Coveler, Douglas A Rubinson, Emma L Welsh, Kathleen Pfaff, Scott Rodig, Stephanie K Dougan, James M Cleary
Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders. Journal for immunotherapy of cancer 12 (1) (2024)
Paul E Oberstein, Andressa Dias Costa, Emily A Kawaler, Victoire Cardot-Ruffino, Osama E Rahma, Nina Beri, Harshabad Singh, Thomas A Abrams, Leah H Biller, James M Cleary, Peter Enzinger, Brandon M Huffman, Nadine Jackson McCleary, Kimberley J Perez, Douglas A Rubinson, Benjamin L Schlechter, Rishi Surana, Matthew B Yurgelun, S Jennifer Wang, Joshua Remland, Lauren K Brais, Naima Bollenrucher, Eugena Chang, Lestat R Ali, Patrick J Lenehan, Igor Dolgalev, Gregor Werba, Cibelle Lima, C Elizabeth Keheler, Keri M Sullivan, Michael L Dougan, Cristina Hajdu, Maya Dajee, Marc R Pelletier, Saloney Nazeer, Matthew Squires, Dafna Bar-Sagi, Brian M Wolpin, Jonathan Andrew Nowak, Diane M Simeone, Stephanie K Dougan
Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor. Cancer immunology research 12 (9) (2024)
Harshabad Singh, Pranshu Sahgal, Kevin S Kapner, Steven M Corsello, Hersh V Gupta, Rahul Gujrathi, Yvonne Y Li, Andrew D Cherniak, Raquelle El Alam, Joseph A Kerfoot, Elizabeth Andrews, Annette Lee, Chetan Nambiar, Alison M Hannigan, Joshua Remland, Lauren K Brais, Meghan E Leahy, Douglas A Rubinson, Benjamin L Schlechter, Matthew L Meyerson, Yanan Kuang, Cloud P Paweletz, Jessica K Lee, Julia Coelho França Quintanilha, Andrew J Aguirre, Kimberley J Perez, Brandon M Huffman, Humberto Rossi, Thomas A Abrams, Sheheryar K Kabraji, Livio Trusolino, Andrea Bertotti, Ewa T Sicinska, Aparna Raj Parikh, Brian M Wolpin, Alexa B Schrock, Marios Giannakis, Kimmie Ng, Jeffrey A Meyerhardt, Jason L Hornick, Nilay S Sethi, James M Cleary
RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (8) (2024)
Brandon M Huffman, Harshabad Singh, Lestat R Ali, Nora Horick, S Jennifer Wang, Megan T Hoffman, Katherine A Metayer, Shayla Murray, Alexandra Bird, Thomas A Abrams, Leah H Biller, Jennifer A Chan, Jeffrey A Meyerhardt, Nadine J McCleary, Wolfram Goessling, Anuj K Patel, Jeffrey S Wisch, Matthew B Yurgelun, Kent Mouw, Brendan Reardon, Eliezer Van Allen, Jessica A Zerillo, Jeffrey W Clark, Aparna Parikh, Robert J Mayer, Benjamin Schlechter, Kimmie Ng, Sunil Kumar, Catherine Del Vecchio Fitz, Charlotte Kuperwasser, Glenn J Hanna, Andrew L Coveler, Douglas A Rubinson, Emma L Welsh, Kathleen Pfaff, Scott Rodig, Stephanie K Dougan, James M Cleary
Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders. Journal for immunotherapy of cancer 12 (1) (2024)
Harshabad Singh, Pranshu Sahgal, Kevin S Kapner, Steven M Corsello, Hersh V Gupta, Rahul Gujrathi, Yvonne Y Li, Andrew D Cherniak, Raquelle El Alam, Joseph A Kerfoot, Elizabeth Andrews, Annette Lee, Chetan Nambiar, Alison M Hannigan, Joshua Remland, Lauren K Brais, Meghan E Leahy, Douglas A Rubinson, Benjamin L Schlechter, Matthew L Meyerson, Yanan Kuang, Cloud P Paweletz, Jessica K Lee, Julia Coelho França Quintanilha, Andrew J Aguirre, Kimberley J Perez, Brandon M Huffman, Humberto Rossi, Thomas A Abrams, Sheheryar K Kabraji, Livio Trusolino, Andrea Bertotti, Ewa T Sicinska, Aparna Raj Parikh, Brian M Wolpin, Alexa B Schrock, Marios Giannakis, Kimmie Ng, Jeffrey A Meyerhardt, Jason L Hornick, Nilay S Sethi, James M Cleary
RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (8) (2024)
Brandon M Huffman, Harshabad Singh, Lestat R Ali, Nora Horick, S Jennifer Wang, Megan T Hoffman, Katherine A Metayer, Shayla Murray, Alexandra Bird, Thomas A Abrams, Leah H Biller, Jennifer A Chan, Jeffrey A Meyerhardt, Nadine J McCleary, Wolfram Goessling, Anuj K Patel, Jeffrey S Wisch, Matthew B Yurgelun, Kent Mouw, Brendan Reardon, Eliezer Van Allen, Jessica A Zerillo, Jeffrey W Clark, Aparna Parikh, Robert J Mayer, Benjamin Schlechter, Kimmie Ng, Sunil Kumar, Catherine Del Vecchio Fitz, Charlotte Kuperwasser, Glenn J Hanna, Andrew L Coveler, Douglas A Rubinson, Emma L Welsh, Kathleen Pfaff, Scott Rodig, Stephanie K Dougan, James M Cleary
Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders. Journal for immunotherapy of cancer 12 (1) (2024)
Harshabad Singh, Kristen E Lowder, Kevin Kapner, Ronan J Kelly, Hui Zheng, Nadine Jackson McCleary, Thomas A Abrams, Jennifer A Chan, Eileen M Regan, Samuel J Klempner, Alison M Hannigan, Joshua Remland, Lauren K Brais, Elizabeth Andrews, Matthew B Yurgelun, James M Cleary, Douglas A Rubinson, Lauren L Ritterhouse, Garrett Maron, Andrew J Aguirre, Jeffrey A Meyerhardt, Emma Gardecki, Jochen K Lennerz, Brian M Wolpin, Peter C Enzinger
Clinical outcomes and ctDNA correlates for CAPOX BETR: a phase II trial of capecitabine, oxaliplatin, bevacizumab, trastuzumab in previously untreated advanced HER2+ gastroesophageal adenocarcinoma. Nature communications 15 (1) (2024)
Harshabad Singh, Pranshu Sahgal, Kevin S Kapner, Steven M Corsello, Hersh V Gupta, Rahul Gujrathi, Yvonne Y Li, Andrew D Cherniak, Raquelle El Alam, Joseph A Kerfoot, Elizabeth Andrews, Annette Lee, Chetan Nambiar, Alison M Hannigan, Joshua Remland, Lauren K Brais, Meghan E Leahy, Douglas A Rubinson, Benjamin L Schlechter, Matthew L Meyerson, Yanan Kuang, Cloud P Paweletz, Jessica K Lee, Julia Coelho França Quintanilha, Andrew J Aguirre, Kimberley J Perez, Brandon M Huffman, Humberto Rossi, Thomas A Abrams, Sheheryar K Kabraji, Livio Trusolino, Andrea Bertotti, Ewa T Sicinska, Aparna Raj Parikh, Brian M Wolpin, Alexa B Schrock, Marios Giannakis, Kimmie Ng, Jeffrey A Meyerhardt, Jason L Hornick, Nilay S Sethi, James M Cleary
RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (8) (2024)
Douglas A Rubinson, Noritaka Tanaka, Ferran Fece de la Cruz, Kevin S Kapner, Michael H Rosenthal, Bryanna L Norden, Haley Barnes, Sara Ehnstrom, Alvin A Morales-Giron, Lauren K Brais, Christopher T Lemke, Andrew J Aguirre, Ryan B Corcoran
Sotorasib is a pan-RASG12C inhibitor capable of driving clinical response in NRASG12C cancers. Cancer discovery (2024)
Harshabad Singh, Pranshu Sahgal, Kevin S Kapner, Steven M Corsello, Hersh V Gupta, Rahul Gujrathi, Yvonne Y Li, Andrew D Cherniak, Raquelle El Alam, Joseph A Kerfoot, Elizabeth Andrews, Annette Lee, Chetan Nambiar, Alison M Hannigan, Joshua Remland, Lauren K Brais, Meghan E Leahy, Douglas A Rubinson, Benjamin L Schlechter, Matthew L Meyerson, Yanan Kuang, Cloud P Paweletz, Jessica K Lee, Julia Coelho França Quintanilha, Andrew J Aguirre, Kimberley J Perez, Brandon M Huffman, Humberto Rossi, Thomas A Abrams, Sheheryar K Kabraji, Livio Trusolino, Andrea Bertotti, Ewa T Sicinska, Aparna Raj Parikh, Brian M Wolpin, Alexa B Schrock, Marios Giannakis, Kimmie Ng, Jeffrey A Meyerhardt, Jason L Hornick, Nilay S Sethi, James M Cleary
RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (8) (2024)
Harshabad Singh, Pranshu Sahgal, Kevin S Kapner, Steven M Corsello, Hersh V Gupta, Rahul Gujrathi, Yvonne Y Li, Andrew D Cherniak, Raquelle El Alam, Joseph A Kerfoot, Elizabeth Andrews, Annette Lee, Chetan Nambiar, Alison M Hannigan, Joshua Remland, Lauren K Brais, Meghan E Leahy, Douglas A Rubinson, Benjamin L Schlechter, Matthew L Meyerson, Yanan Kuang, Cloud P Paweletz, Jessica K Lee, Julia Coelho França Quintanilha, Andrew J Aguirre, Kimberley J Perez, Brandon M Huffman, Humberto Rossi, Thomas A Abrams, Sheheryar K Kabraji, Livio Trusolino, Andrea Bertotti, Ewa T Sicinska, Aparna Raj Parikh, Brian M Wolpin, Alexa B Schrock, Marios Giannakis, Kimmie Ng, Jeffrey A Meyerhardt, Jason L Hornick, Nilay S Sethi, James M Cleary
RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (8) (2024)
Douglas A Rubinson, Noritaka Tanaka, Ferran Fece de la Cruz, Kevin S Kapner, Michael H Rosenthal, Bryanna L Norden, Haley Barnes, Sara Ehnstrom, Alvin A Morales-Giron, Lauren K Brais, Christopher T Lemke, Andrew J Aguirre, Ryan B Corcoran
Sotorasib Is a Pan-RASG12C Inhibitor Capable of Driving Clinical Response in NRASG12C Cancers. Cancer discovery 14 (5) (2024)
Brandon M Huffman, Harshabad Singh, Lestat R Ali, Nora Horick, S Jennifer Wang, Megan T Hoffman, Katherine A Metayer, Shayla Murray, Alexandra Bird, Thomas A Abrams, Leah H Biller, Jennifer A Chan, Jeffrey A Meyerhardt, Nadine J McCleary, Wolfram Goessling, Anuj K Patel, Jeffrey S Wisch, Matthew B Yurgelun, Kent Mouw, Brendan Reardon, Eliezer Van Allen, Jessica A Zerillo, Jeffrey W Clark, Aparna Parikh, Robert J Mayer, Benjamin Schlechter, Kimmie Ng, Sunil Kumar, Catherine Del Vecchio Fitz, Charlotte Kuperwasser, Glenn J Hanna, Andrew L Coveler, Douglas A Rubinson, Emma L Welsh, Kathleen Pfaff, Scott Rodig, Stephanie K Dougan, James M Cleary
Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders. Journal for immunotherapy of cancer 12 (1) (2024)
Harshabad Singh, Kristen E Lowder, Kevin Kapner, Ronan J Kelly, Hui Zheng, Nadine Jackson McCleary, Thomas A Abrams, Jennifer A Chan, Eileen M Regan, Samuel J Klempner, Alison M Hannigan, Joshua Remland, Lauren K Brais, Elizabeth Andrews, Matthew B Yurgelun, James M Cleary, Douglas A Rubinson, Lauren L Ritterhouse, Garrett Maron, Andrew J Aguirre, Jeffrey A Meyerhardt, Emma Gardecki, Jochen K Lennerz, Brian M Wolpin, Peter C Enzinger
Clinical outcomes and ctDNA correlates for CAPOX BETR: a phase II trial of capecitabine, oxaliplatin, bevacizumab, trastuzumab in previously untreated advanced HER2+ gastroesophageal adenocarcinoma. Nature communications 15 (1) (2024)
Douglas A Rubinson, Noritaka Tanaka, Ferran Fece de la Cruz, Kevin S Kapner, Michael H Rosenthal, Bryanna L Norden, Haley Barnes, Sara Ehnstrom, Alvin A Morales-Giron, Lauren K Brais, Christopher T Lemke, Andrew J Aguirre, Ryan B Corcoran
Sotorasib Is a Pan-RASG12C Inhibitor Capable of Driving Clinical Response in NRASG12C Cancers. Cancer discovery 14 (5) (2024)
Douglas A Rubinson, Noritaka Tanaka, Ferran Fece de la Cruz, Kevin S Kapner, Michael H Rosenthal, Bryanna L Norden, Haley Barnes, Sara Ehnstrom, Alvin A Morales-Giron, Lauren K Brais, Christopher T Lemke, Andrew J Aguirre, Ryan B Corcoran
Sotorasib Is a Pan-RASG12C Inhibitor Capable of Driving Clinical Response in NRASG12C Cancers. Cancer discovery 14 (5) (2024)
Brandon M Huffman, Hanrong Feng, Kalindi Parmar, Junning Wang, Kevin S Kapner, Bose S Kochupurakkal, David B Martignetti, Golbahar Sadatrezaei, Thomas A Abrams, Leah H Biller, Marios Giannakis, Kimmie Ng, Anuj K Patel, Kimberley J Perez, Harshabad Singh, Douglas A Rubinson, Benjamin L Schlechter, Elizabeth Andrews, Alison M Hannigan, Stanley Dunwell, Zoe Getchell, Srivatsan Raghavan, Brian M Wolpin, Caroline Fortier, Alan D' Andrea, Andrew J Aguirre, Geoffrey I Shapiro, James M Cleary
A Phase 1 Expansion Cohort Study Evaluating the Safety and Efficacy of the CHK1 Inhibitor LY2880070 with Low-Dose Gemcitabine in Metastatic Pancreatic Adenocarcinoma Patients. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Afsaneh Barzi, Angela J Kim, Crystal K Liang, Howard Jack West, D Wong, Carol Wright, Nitya Nathwani, Catherine M Vasko, Vincent Chung, Douglas A Rubinson, Todd Sachs
Pancreatic Adenocarcinoma: Real World Evidence of Care Delivery in AccessHope Data. Journal of personalized medicine 13 (9) (2023)
Victoire Cardot-Ruffino, Naima Bollenrucher, Luisa Delius, S Jennifer Wang, Lauren K Brais, Joshua Remland, C Elizabeth Keheler, Keri M Sullivan, Thomas A Abrams, Leah H Biller, Peter C Enzinger, Nadine J McCleary, Anuj K Patel, Douglas A Rubinson, Benjamin Schlechter, Sarah Slater, Matthew B Yurgelun, James M Cleary, Kimberly Perez, Michael Dougan, Kimmie Ng, Brian M Wolpin, Harshabad Singh, Stephanie K Dougan
G-CSF rescue of FOLFIRINOX-induced neutropenia leads to systemic immune suppression in mice and humans. Journal for immunotherapy of cancer 11 (6) (2023)
Harshabad Singh, Rachel B Keller, Kevin S Kapner, Julien Dilly, Srivatsan Raghavan, Chen Yuan, Elizabeth F Cohen, Michael Yevgeniy Tolstorukov, Elizabeth Andrews, Lauren K Brais, Annacarolina F L Da Silva, Kimberley J Perez, Douglas A Rubinson, Rishi Surana, Marios Giannakis, Kimmie Ng, Thomas E Clancy, Matthew B Yurgelun, Benjamin L Schlechter, Jeffrey W Clark, Geoffrey I Shapiro, Michael H Rosenthal, Jason L Hornick, Valentina Nardi, Yvonne Y Li, Hersh V Gupta, Andrew D Cherniak, Matthew L Meyerson, James M Cleary, Jonathan Andrew Nowak, Brian M Wolpin, Andrew J Aguirre
Oncogenic drivers and therapeutic vulnerabilities in KRAS wild-type pancreatic cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Andressa Dias Costa, Sara A Väyrynen, Akhil Chawla, Jinming Zhang, Juha P Väyrynen, Mai Chan Lau, Hannah L Williams, Chen Yuan, Vicente Morales-Oyarvide, Dalia Elganainy, Harshabad Singh, James M Cleary, Kimberley J Perez, Kimmie Ng, William A Freed-Pastor, Joseph D Mancias, Stephanie K Dougan, Jiping Wang, Douglas A Rubinson, Richard F Dunne, Margaret M Kozak, Lauren K Brais, Emma R Hill, Thomas E Clancy, David C Linehan, Daniel T Chang, Aram F Hezel, Albert C Koong, Andrew J Aguirre, Brian M Wolpin, Jonathan Andrew Nowak
Neoadjuvant Chemotherapy Is Associated with Altered Immune Cell Infiltration and an Anti-Tumorigenic Microenvironment in Resected Pancreatic Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (23) (2022)
Brandon M Huffman, Haley Ellis, Alexander C Jordan, William A Freed-Pastor, Kimberly Perez, Douglas A Rubinson, Nilay S Sethi, Harshabad Singh, Rishi Surana, Brian M Wolpin, Andrew J Aguirre, James M Cleary
Emerging Role of Targeted Therapy in Metastatic Pancreatic Adenocarcinoma. Cancers 14 (24) (2022)
Brandon M Huffman, Haley Ellis, Alexander C Jordan, William A Freed-Pastor, Kimberly Perez, Douglas A Rubinson, Nilay S Sethi, Harshabad Singh, Rishi Surana, Brian M Wolpin, Andrew J Aguirre, James M Cleary
Emerging Role of Targeted Therapy in Metastatic Pancreatic Adenocarcinoma. Cancers 14 (24) (2022)
Leonie K de Klerk, Anuj K Patel, Sarah Derks, Eirini Pectasides, Jérémy Augustin, Mohamed Uduman, Nihal Raman, Fahire G Akarca, Nadine J McCleary, James M Cleary, Douglas A Rubinson, Jeffrey W Clark, Bridget Fitzpatrick, Lauren K Brais, Megan E Cavanaugh, Amanda J Rode, Melissa G Jean, Patrick H Lizotte, Matthew J Nazzaro, Mariano Severgnini, Hui Zheng, Charles S Fuchs, Peter C Enzinger, Adam J Bass
Phase II study of pembrolizumab in refractory esophageal cancer with correlates of response and survival. Journal for immunotherapy of cancer 9 (9) (2022)
Hannah L Williams, Andressa Dias Costa, Jinming Zhang, Srivatsan Raghavan, Peter S Winter, Kevin S Kapner, Scott P Ginebaugh, Sara A Väyrynen, Juha P Väyrynen, Chen Yuan, Andrew W Navia, Junning Wang, Annan Yang, Timothy L Bosse, Radha L Kalekar, Kristen E Lowder, Mai Chan Lau, Dalia Elganainy, Vicente Morales-Oyarvide, Douglas A Rubinson, Harshabad Singh, Kimberley J Perez, James M Cleary, Thomas E Clancy, Jiping Wang, Joseph D Mancias, Lauren K Brais, Emma R Hill, Margaret M Kozak, David C Linehan, Richard F Dunne, Daniel T Chang, Albert C Koong, Aram F Hezel, William C Hahn, Alex K Shalek, Andrew J Aguirre, Jonathan Andrew Nowak, Brian M Wolpin
Spatially-resolved single-cell assessment of pancreatic cancer expression subtypes reveals co-expressor phenotypes and extensive intra-tumoral heterogeneity. Cancer research (2022)
James M Cleary, Srivatsan Raghavan, Qibiao Wu, Yvonne Y Li, Liam F Spurr, Hersh V Gupta, Douglas A Rubinson, Isobel J Fetter, Jason L Hornick, Jonathan A Nowak, Giulia Siravegna, Lipika Goyal, Lei Shi, Lauren K Brais, Maureen Loftus, Atul B Shinagare, Thomas A Abrams, Thomas E Clancy, Jiping Wang, Anuj K Patel, Franck Brichory, Anne Vaslin Chessex, Ryan J Sullivan, Rachel B Keller, Sarah Denning, Emma R Hill, Geoffrey I Shapiro, Anna Pokorska-Bocci, Claudio Zanna, Kimmie Ng, Deborah Schrag, Pasi A Jänne, William C Hahn, Andrew D Cherniack, Ryan B Corcoran, Matthew Meyerson, Antoine Daina, Vincent Zoete, Nabeel Bardeesy, Brian M Wolpin
FGFR2 Extracellular Domain In-Frame Deletions Are Therapeutically Targetable Genomic Alterations That Function as Oncogenic Drivers in Cholangiocarcinoma. Cancer discovery 11 (10) (2021)
Shannon M Liudahl, Courtney B Betts, Shamilene Sivagnanam, Vicente Morales-Oyarvide, Annacarolina F L Da Silva, Chen Yuan, Samuel Hwang, Alison Grossblatt-Wait, Kenna R Leis, William Larson, Meghan B Lavoie, Padraic Robinson, Andressa Dias Costa, Sara A Väyrynen, Thomas E Clancy, Douglas A Rubinson, Jason Link, Dove Keith, Wesley Horton, Margaret A Tempero, Robert A Anders, Elizabeth D Thompson, Brett Sheppard, Jeremy Goecks, Rosalie C Sears, Byung S Park, Motomi Mori, Jonathan A Nowak, Brian M Wolpin, Lisa M Coussens
Leukocyte Heterogeneity in Pancreatic Ductal Adenocarcinoma: Phenotypic and Spatial Features Associated with Clinical Outcome. Cancer discovery 11 (8) (2021)
Juha P Väyrynen, Jinming Zhang, Chen Yuan, Andressa Dias Costa, Hannah L Williams, Vicente Morales-Oyarvide, Mai Chan Lau, Douglas A Rubinson, Richard F Dunne, Margaret M Kozak, Wenjia Wang, Diana Agostini-Vulaj, Michael G Drage, Lauren Brais, Emma Reilly, Osama Rahma, Thomas Clancy, Jiping Wang, David C Linehan, Andrew J Aguirre, Charles S Fuchs, Lisa M Coussens, Daniel T Chang, Albert C Koong, Aram F Hezel, Shuji Ogino, Jonathan A Nowak, Brian M Wolpin
Composition, Spatial Characteristics, and Prognostic Significance of Myeloid Cell Infiltration in Pancreatic Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (4) (2020)
Chunxia Du, Annacarolina F L Da Silva, Vicente Morales-Oyarvide, Andressa Dias Costa, Margaret M Kozak, Richard F Dunne, Douglas A Rubinson, Kimberly Perez, Yohei Masugi, Tsuyoshi Hamada, Lauren K Brais, Chen Yuan, Ana Babic, Matthew D Ducar, Aaron R Thorner, Andrew Aguirre, Matthew H Kulke, Kimmie Ng, Thomas E Clancy, Jennifer J Findeis-Hosey, Daniel T Chang, Jason L Hornick, Charles S Fuchs, Shuji Ogino, Albert C Koong, Aram F Hezel, Brian M Wolpin, Jonathan A Nowak
Insulin-Like Growth Factor-1 Receptor Expression and Disease Recurrence and Survival in Patients with Resected Pancreatic Ductal Adenocarcinoma. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 29 (8) (2020)
Justin C Brown, Michael H Rosenthal, Chao Ma, Sui Zhang, Halla S Nimeiri, Nadine J McCleary, Thomas A Abrams, Matthew B Yurgelun, James M Cleary, Douglas A Rubinson, Deborah Schrag, Andrea J Bullock, Jill Allen, Dan Zuckerman, Emily Chan, Jennifer A Chan, Brian Wolpin, Michael Constantine, Douglas J Weckstein, Meredith A Faggen, Christian A Thomas, Chryssanthi Kournioti, Chen Yuan, Hui Zheng, Bruce W Hollis, Charles S Fuchs, Kimmie Ng, Jeffrey A Meyerhardt
Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Body Composition among Patients with Advanced or Metastatic Colorectal Cancer: A Randomized Trial. Cancers 12 (11) (2020)